Cutting edge: ICOS-deficient regulatory T cells display normal induction of Il10 but readily downregulate expression of Foxp3

AE Landuyt, BJ Klocke, TB Colvin… - The Journal of …, 2019 - journals.aai.org
AE Landuyt, BJ Klocke, TB Colvin, TR Schoeb, CL Maynard
The Journal of Immunology, 2019journals.aai.org
The ICOS pathway has been implicated in the development and functions of regulatory T
(Treg) cells, including those producing IL-10. Treg cell–derived IL-10 is indispensable for the
establishment and maintenance of intestinal immune homeostasis. We examined the
possible involvement of the ICOS pathway in the accumulation of murine colonic Foxp3-
and/or IL-10–expressing cells. We show that ICOS deficiency does not impair induction of IL-
10 by intestinal CD4 T cells but, instead, triggers substantial reductions in gut-resident and …
Abstract
The ICOS pathway has been implicated in the development and functions of regulatory T (Treg) cells, including those producing IL-10. Treg cell–derived IL-10 is indispensable for the establishment and maintenance of intestinal immune homeostasis. We examined the possible involvement of the ICOS pathway in the accumulation of murine colonic Foxp3-and/or IL-10–expressing cells. We show that ICOS deficiency does not impair induction of IL-10 by intestinal CD4 T cells but, instead, triggers substantial reductions in gut-resident and peripherally derived Foxp3+ Treg cells. ICOS deficiency is associated with reduced demethylation of Foxp3 CNS2 and enhanced loss of Foxp3. This instability significantly limits the ability of ICOS-deficient Treg cells to reverse ongoing inflammation. Collectively, our results identify a novel role for ICOS costimulation in imprinting the functional stability of Foxp3 that is required for the retention of full Treg cell function in the periphery.
journals.aai.org